CLL Society

Bruce Wright's story is one of strength and commitment to helping fellow individuals with CLL and veterans. In his article, Bruce recounts pivotal moments of his life and navigating the complexities of living with cancer. https://bit.ly/3zTDqEa

Frontline therapy selection for chronic lymphocytic leukemia (CLL) carries implications for sequential care, which increases the complexity of clinical decision-making in relapsed/refractory (R/R) disease. Join us on 10/17 or 10/24 at 7pm EDT for a virtual workshop hosted in collaboration with our partner PVI, PeerView Institute for Medical Education, which will pair mini lectures with case-based instruction and feature a panel of academic and community-based clinicians, will model the importance of collaborative decision-making for the optimal integration of non-covalent BTKi and CAR-T therapies for the treatment of R/R CLL. Register today to join in and build a resilient community of care! https://bit.ly/2024CLLL #MedEd

Learn about a new, experimental CAR-T therapy that is being tested in a Phase I clinical trial for CLL/SLL. https://bit.ly/3ZUM5kx

Join us in one week with Dr. Michael Choi as we discuss how to optimize your CLL treatment. Learn about strategies to stay on treatment, managing side effects, and more. CLL Patient Advocate Larry Marion will join to moderate the discussion. Register at: https://bit.ly/3XPM12V

If you missed the recent webinar on comprehensive health management with nurse practitioner Amy Goodrich, you can catch the replay, presentation slides, and transcript here! https://bit.ly/3T8O94a

This study looked at how those with CLL being treated with acalabrutinib can become resistant to the medication over time. https://bit.ly/4ewLDx8

Researchers examined the potential benefits of exercise for those living with CLL while on treatment. https://bit.ly/3ZJOOx4

Researchers specifically looked at how individuals with small lymphocytic lymphoma (SLL) did on their first of treatment to better understand this patient population. https://bit.ly/47o5FHo

Proud to partner with the Lymphoma, Leukemia & Myeloma Congress this year! Supporting this healthcare provider vital event means contributing to the advancement of research and treatment for hematologic malignancies. Together, we are committed to fostering innovation and improving patient care. Looking forward to an inspiring and impactful experience! #LLMCongress2024 #PartnershipForProgress #Hematology #oncology Register to attend: www.lymphomaandmyeloma.com

Join CLL Society on October 16th at 11am PT / 2pm ET for our webinar, Getting the Most from Your CLL Treatment: Managing Side Effects and Knowing When to Stop. With Dr. Michael Choi, we will go over optimizing your CLL treatment, including how to manage side effects and when it might be time to consider making a change in your therapy. Learn more and register at: https://bit.ly/3XPM12V